Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Argus Health
Dow
AstraZeneca
McKinsey
Fish and Richardson
Julphar
QuintilesIMS
Johnson and Johnson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Drug Master Files for: mycophenolate

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
16406AII1/20/2003BIOCON LTDMYCOPHENOLATE MOFETIL
18494AII7/11/2005CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDMYCOPHENOLATE MOFETIL USP
18936AII11/7/2005LEK PHARMACEUTICALS DDMYCOPHENOLATE MOFETIL
18989III11/28/2005IVAX PHARMACEUTICALS SROMYCOPHENOLATE MOFETIL USP
19231AII3/7/2006CONCORD BIOTECH LTDMYCOPHENOLATE MOFETIL USP
20072AII12/20/2006TEVA PHARMACEUTICAL INDUSTRIES LTDMYCOPHENOLATE MOFETIL DRUG SUBSTANCE
20655AII7/2/2007SHANDONG NEW TIME PHARMACEUTICAL CO LTDMYCOPHENOLATE MOFETIL
20679III11/7/2007CIPLA LTDMYCOPHENOLATE MOFETIL BP/PH. EUR.
20758III8/7/2007CHONGQING DAXIN PHARMACEUTICAL CO LTDMYCOPHENOLATE MOFETIL, NON-STERILE BULK DRUG SUBSTANCE
20948III10/15/2007EXCELLA GMBHMYCOPHENOLATE MOFETIL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
Colorcon
Boehringer Ingelheim
Harvard Business School
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Queensland Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot